Diagnostics

A landmark study validates Panakeia's AI, which provides critical cancer biomarker results in minutes, promising to revolutionize patient care globally.

A massive NHS trial in The Lancet shows AI-powered stethoscopes dramatically improve early detection of heart disease. Is this the future of primary care?

With new manufacturing deals, CS Diagnostics is set to enter the competitive global hygiene market, targeting infection control from hospitals to homes.

As new CDC data reveals autism affects 1 in 31 children, one provider is rapidly expanding its workforce and centers to address a growing public health crisis.

Following its acquisition, ASP Isotopes reports a dramatic turnaround at the Renergen project, with gas output up 60% and new discoveries boosting its outlook.

The new SecureFlex™ device aims to improve tissue sampling for diseases like pancreatic cancer, enabling more precise diagnoses and personalized treatments.

A new study reveals an AI-powered metric better predicts sleep apnea symptoms than traditional tests, promising more accurate diagnoses, especially for women.

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

Top scientists, survivors, and industry leaders are uniting to accelerate a new generation of cancer vaccines, moving them from lab to patient faster than ever.

New data reveals Orasis Pharma's Qlosi eye drops offer a 'pupil selective' approach to presbyopia, promising fewer side effects than rival treatments.

Myriad Genetics is launching a new cancer test that promises to detect recurrence earlier than ever. But can it win in a competitive market?

New research provides the strongest human evidence that sleep actively clears toxic proteins linked to Alzheimer's, opening a new frontier for prevention.

A new study reveals albumin, the most abundant protein in blood, is a powerful weapon against mucormycosis, offering new hope for treating this fatal infection.

A new study confirms AI can detect major heart conditions from one brief ultrasound clip, empowering any clinician to perform life-saving cardiac screening.

As consolidation reshapes healthcare, Integrated Dermatology's new CMO appointment signals a strategic move to blend clinical leadership with corporate growth.

AEKE's new K1 smart gym combines an AI personal trainer with a disruptive one-time purchase model, aiming to shake up the subscription-heavy fitness market.

A new FDA-cleared test detects RSV, Flu A/B, and COVID from a single swab, offering a powerful diagnostic tool for families, especially for infants.

Acrivon Therapeutics to unveil pivotal data showing high response rates for its targeted drug ACR-368 in an aggressive endometrial cancer subtype.

Ozelle will debut an AI system at WHX Labs Dubai that merges three lab functions into one, promising faster, smarter diagnostics for local clinics.

A new strategic partnership aims to dismantle commercialization hurdles, promising faster access to life-saving therapies for rare disease patients.